Development of Biomarkers for Inhibition of SLC6A19 (B<sup>0</sup>AT1)—A Potential Target to Treat Metabolic Disorders
Recent studies have established that dietary protein restriction improves metabolic health and glucose homeostasis. SLC6A19 (B<sup>0</sup>AT1) is the major neutral amino acid transporter in the intestine and carries out the bulk of amino acid absorption from the diet. Mice lacking SLC6A1...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-11-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/19/11/3597 |